Clinical Trial Update: Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial for transepithelial (epi-on) corneal collagen crosslinking in keratoconus and corneal ectasia is ongoing with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus

Drugs mentioned

• Transepithelial (Epi-on) corneal collagen crosslinking

Snippet

Sponsor: Cornea and Laser Eye Institute | Conditions: Keratoconus, Corneal Ectasia | Phase 3 | Status: UNKNOWN